Glytec

Glytec is a leading Information Technology startup, founded in 2006 and headquartered in the United States. Their slogan, "Glytec’s leading SaaS platform empowers collaborative diabetes management and insulin dosing from the hospital to home," encapsulates their mission. With a SaaS platform trusted by 350+ hospitals, Glytec aims to improve patient outcomes, reduce readmissions, and streamline workflows, delivering a remarkable 6-8x ROI. The company's first-ever FDA-cleared cloud-based insulin management software is EMR-integrated, easy to set up, and validated by 106 patents and over 100 publications. Their Glytec Glucommander® solution incorporates clinical decision support, workflow alerts, patient monitoring, at-risk patient identification, and AI-driven analytics. Glytec's mission-driven team is dedicated to helping healthcare leaders, clinicians, and patients promote health equity and improve diabetes outcomes, from hospital to home. Although information about their last funding round and investors is not available at the moment, Glytec's dedication to revolutionizing diabetes management makes them an intriguing prospect for venture capitalists seeking opportunities in the healthcare technology space. Keep an eye on Glytec for future developments by following them on X (@Glytec) or visiting www.Glytec.com.